CN112316104A - 鲟鱼骨肽在制备神经保护制剂中的应用及产品 - Google Patents
鲟鱼骨肽在制备神经保护制剂中的应用及产品 Download PDFInfo
- Publication number
- CN112316104A CN112316104A CN202011249424.3A CN202011249424A CN112316104A CN 112316104 A CN112316104 A CN 112316104A CN 202011249424 A CN202011249424 A CN 202011249424A CN 112316104 A CN112316104 A CN 112316104A
- Authority
- CN
- China
- Prior art keywords
- bone peptide
- sturgeon bone
- peptide
- alcohol
- sturgeon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 105
- 241000881711 Acipenser sturio Species 0.000 title claims abstract description 65
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 230000000324 neuroprotective effect Effects 0.000 title abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 59
- 230000004060 metabolic process Effects 0.000 claims abstract description 9
- 208000024891 symptom Diseases 0.000 claims abstract description 8
- 206010033799 Paralysis Diseases 0.000 claims abstract description 7
- 208000028389 Nerve injury Diseases 0.000 claims abstract description 3
- 230000008764 nerve damage Effects 0.000 claims abstract description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 13
- 229910052711 selenium Inorganic materials 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 229920001184 polypeptide Polymers 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- 235000013373 food additive Nutrition 0.000 claims description 11
- 239000002778 food additive Substances 0.000 claims description 11
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 claims description 10
- 102000003792 Metallothionein Human genes 0.000 claims description 10
- 108090000157 Metallothionein Proteins 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 210000005036 nerve Anatomy 0.000 claims description 6
- 230000004224 protection Effects 0.000 claims description 3
- 206010019133 Hangover Diseases 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 38
- 230000000694 effects Effects 0.000 abstract description 15
- 238000010171 animal model Methods 0.000 abstract description 3
- 208000020401 Depressive disease Diseases 0.000 abstract description 2
- 201000003102 mental depression Diseases 0.000 abstract description 2
- 239000002585 base Substances 0.000 description 30
- 238000012360 testing method Methods 0.000 description 28
- 241000699670 Mus sp. Species 0.000 description 26
- 230000035622 drinking Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 125000003158 alcohol group Chemical group 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
- 206010006326 Breath odour Diseases 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 108010059892 Cellulase Proteins 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000028527 righting reflex Effects 0.000 description 3
- 108010004032 Bromelains Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003930 cognitive ability Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000037323 metabolic rate Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 239000000816 peptidomimetic Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012048 forced swim test Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
检测项目 | 检测结果 | 单位 |
肽总量 | 89.17 | % |
分子量分布 | 242 | Da |
分子量分布(Da) | 百分比(%) |
>2300 | 0.0 |
2300-1200 | 0.42 |
1199-580 | 5.62 |
579-242 | 6.69 |
<243 | 87.27 |
组别 | 小鼠只数 | 醉酒只数 | 醉酒时间/min | 醒酒时间/min |
基酒组 | 20 | 20 | 23.58±1.64 | 292.75±13.48 |
鲟鱼骨肽(肽度酒)组 | 20 | 20 | 39.86±2.21** | 195.37±17.43** |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011249424.3A CN112316104B (zh) | 2020-11-10 | 2020-11-10 | 鲟鱼骨肽在制备神经保护制剂中的应用及产品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011249424.3A CN112316104B (zh) | 2020-11-10 | 2020-11-10 | 鲟鱼骨肽在制备神经保护制剂中的应用及产品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112316104A true CN112316104A (zh) | 2021-02-05 |
CN112316104B CN112316104B (zh) | 2024-06-11 |
Family
ID=74319104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011249424.3A Active CN112316104B (zh) | 2020-11-10 | 2020-11-10 | 鲟鱼骨肽在制备神经保护制剂中的应用及产品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112316104B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114246884A (zh) * | 2021-12-13 | 2022-03-29 | 广东海洋大学 | 红鱼酶解物在改善慢性应激诱发的抑郁样行为方面的应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070032843A (ko) * | 2005-09-20 | 2007-03-23 | 주식회사 브레인가드 | 알코올성 뇌기능손상 회복 및 숙취해소용 조성물 |
JP2008127355A (ja) * | 2006-11-22 | 2008-06-05 | Yaizu Suisankagaku Industry Co Ltd | アルコール酔い軽減用組成物及びそれを含有する飲食品 |
CN102049036A (zh) * | 2009-11-06 | 2011-05-11 | 李勇 | 海洋胶原肽在制备防醉酒的药物、保健食品或食品中的用途 |
WO2012049430A2 (fr) * | 2010-10-14 | 2012-04-19 | V. Mane Fils | Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices |
CN110218756A (zh) * | 2019-05-31 | 2019-09-10 | 嫦娥创新(武汉)生物科技有限公司 | 一种具有抗衰作用的富硒鲟鱼骨肽提取方法及产品 |
CN111202836A (zh) * | 2020-02-07 | 2020-05-29 | 嫦娥创新(武汉)生物科技有限公司 | 鲟鱼蛋白肽在制备免疫调节制剂中的应用 |
CN111718825A (zh) * | 2020-06-24 | 2020-09-29 | 贵州古得宁酒业有限公司 | 一种具有补肾益阳作用的鲟鱼骨肽酒、其制备方法及应用 |
-
2020
- 2020-11-10 CN CN202011249424.3A patent/CN112316104B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070032843A (ko) * | 2005-09-20 | 2007-03-23 | 주식회사 브레인가드 | 알코올성 뇌기능손상 회복 및 숙취해소용 조성물 |
JP2008127355A (ja) * | 2006-11-22 | 2008-06-05 | Yaizu Suisankagaku Industry Co Ltd | アルコール酔い軽減用組成物及びそれを含有する飲食品 |
CN102049036A (zh) * | 2009-11-06 | 2011-05-11 | 李勇 | 海洋胶原肽在制备防醉酒的药物、保健食品或食品中的用途 |
WO2012049430A2 (fr) * | 2010-10-14 | 2012-04-19 | V. Mane Fils | Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices |
CN110218756A (zh) * | 2019-05-31 | 2019-09-10 | 嫦娥创新(武汉)生物科技有限公司 | 一种具有抗衰作用的富硒鲟鱼骨肽提取方法及产品 |
CN111202836A (zh) * | 2020-02-07 | 2020-05-29 | 嫦娥创新(武汉)生物科技有限公司 | 鲟鱼蛋白肽在制备免疫调节制剂中的应用 |
CN111718825A (zh) * | 2020-06-24 | 2020-09-29 | 贵州古得宁酒业有限公司 | 一种具有补肾益阳作用的鲟鱼骨肽酒、其制备方法及应用 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114246884A (zh) * | 2021-12-13 | 2022-03-29 | 广东海洋大学 | 红鱼酶解物在改善慢性应激诱发的抑郁样行为方面的应用 |
CN114246884B (zh) * | 2021-12-13 | 2023-12-22 | 广东海洋大学 | 红鱼酶解物在改善慢性应激诱发的抑郁样行为方面的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112316104B (zh) | 2024-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mazokopakis et al. | Acute rhabdomyolysis caused by Spirulina (Arthrospira platensis) | |
CN104144698A (zh) | 治疗神经和精神障碍的行为症状的方法 | |
CN102149383B (zh) | 化合物在制备用于治疗通过抑制血清素再吸收而改善的疾病的医药品或饮食品中的用途 | |
US8791060B2 (en) | Composition and use of phyto-percolate for treatment of disease | |
CN107343584A (zh) | 具有抗疲劳功能的发酵饮料及制备方法 | |
CN105287430A (zh) | 一种藻油软胶囊及其制造方法 | |
CN106039050A (zh) | 一种益生菌发酵玉米须的组合物及其制备方法和应用 | |
Sabo et al. | Pharmacodynamic action of a commercial preparation of the mushroom Coprinus comatus in rats | |
EP1954800A2 (en) | Composition and use of phyto-percolate for treatment of disease | |
CN112316104A (zh) | 鲟鱼骨肽在制备神经保护制剂中的应用及产品 | |
CN101888847A (zh) | 含有全果实Zanthoxylum Bungeanum提取物的营养药物性组合物 | |
CN112852670B (zh) | 一种婴儿双歧杆菌dh231及其发酵产物、应用和微生态制剂 | |
Wiącek et al. | Different Approaches to Ergogenic, Pre-, and Probiotic Supplementation in Sports with Different Metabolism Characteristics: A Mini Review | |
CN109680021A (zh) | 一种低分子量硫酸软骨素及其制备工艺与在治疗阿尔茨海默病中的应用 | |
Therasa et al. | In-vivo and ex-vivo inhibition of intestinal glucose uptake: a scope for antihyperglycemia | |
Hintz et al. | Cultured fish epithelial cells are a source of alarm substance | |
JP2019135983A (ja) | 皮膚の光老化抑制用食品 | |
CN114306409A (zh) | 玛咖外泌体的提取方法及由其提取的玛咖外泌体和应用 | |
CN110495426A (zh) | 一种氨基酸代谢异常的果蝇模型及其应用 | |
TWI619499B (zh) | 黑柄炭角菌菌絲體萃取物保護神經細胞之用途 | |
Merbl et al. | Intermediate syndrome of chlorpyriphos toxicity (Polaris®) in a caracal (Caracal caracal) | |
CN107456485A (zh) | 一种提高免疫力和抗衰老的组合物及其用途和应用产品 | |
CN107136158A (zh) | 一种预防老年痴呆的保健饼干及其制作方法 | |
CN108159028A (zh) | 细辛醚类化合物的用途 | |
RU2186577C1 (ru) | Препарат, обладающий гепатозащитным действием |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240516 Address after: 430070 East Floor, Building C4, Biological Innovation Park, No. 666 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Applicant after: Hubei Chang'e Biological Co.,Ltd. Country or region after: China Address before: 564501 piaoshuitang formation, Yunliu village, Maotai Town, Zunyi City, Guizhou Province Applicant before: Guizhou gudening Liquor Co.,Ltd. Country or region before: China |
|
GR01 | Patent grant |